tiprankstipranks
Carmell Therapeutics (CTCX)
NASDAQ:CTCX
US Market
Holding CTCX?
Track your performance easily

Carmell Therapeutics (CTCX) Income Statement

37 Followers

Carmell Therapeutics Income Statement

Last quarter (Q ), Carmell Therapeutics's total revenue was $20.52K, an increase of Infinity% from the same quarter last year. In Q, Carmell Therapeutics's net income was $-2.88M. See Carmell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
$ 3.76M$ 440.78K--
Cost of Revenue
$ 1.55M$ 4.75M--
Gross Profit
$ 2.21M$ -4.31M--
Operating Expense
$ 11.34M$ 5.94M$ -1.65M$ -467.43K
Operating Income
$ -9.13M$ -5.94M$ -1.65M$ -467.43K
Net Non Operating Interest Income Expense
$ -10.39K$ 889.32K--
Other Income Expense
$ 5.93M$ -10.10M--
Pretax Income
$ -21.20M$ -16.21M$ 596.20K$ -329.38K
Tax Provision
--$ 391.20K$ -96.46K
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -20.97M$ -16.12M$ -3.42M$ 467.43K
Basic EPS
$ -1.20$ -1.46$ 0.02$ -0.06
Diluted EPS
$ -1.20$ -1.46$ 0.02$ -0.06
Basic Average Shares
$ 83.19M$ 11.02M$ 4.32M$ 4.01M
Diluted Average Shares
$ 83.19M$ 11.02M$ 4.32M$ 4.01M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 12.89M$ 10.70M$ -1.65M$ -467.43K
Net Income From Continuing And Discontinued Operation
$ -20.92M$ -15.45M$ -3.42M$ -6.29K
Normalized Income
$ -17.93M-$ 470.99K$ -425.84K
Interest Expense
----
EBIT
$ -17.71M$ -15.32M$ 596.20K$ -329.38K
EBITDA
$ -17.10M$ -15.16M$ 596.20K$ -329.38K
Currency in USD

Carmell Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis